期刊文献+

霉酚酸酯治疗肾小球疾病的临床效果分析 被引量:1

下载PDF
导出
摘要 目的探讨霉酚酸酯治疗肾小球疾病的临床效果。方法选取安钢职工总医院2013年6月至2014年6月收治的62例肾小球疾病患者为研究对象,随机分对照组和观察组,对照组给予环磷酰胺联合中等剂量激素冲击疗法治疗,观察组给予霉酚酸酯联合中等剂量激素治疗,比较两组患者的临床效果和不良反应发生情况。结果治疗后与治疗前比较,两组患者尿素氮和血肌酐水平均明显下降(P<0.05)。治疗后观察组患者尿素氮和血肌酐水平明显低于对照组(P<0.05)。观察组不良反应发生率明显低于对照组(P<0.05)。结论霉酚酸酯治疗肾小球疾病临床效果显著,安全性高,易于被患者接受。
出处 《河南医学研究》 CAS 2015年第6期144-145,共2页 Henan Medical Research
  • 相关文献

参考文献3

二级参考文献26

  • 1王海燕.肾病综合征.//王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:943-944,947-948.
  • 2王海燕.肾脏病学[M].北京:人民卫生出版社,2009:831-834.
  • 3Wu J, Guan TJ, Zheng S, et al. Inhibition of inflammation by pento- san polysulfate impedes the development and progression of severe dia- betic nephropathy in aging C57B6 mice[ J]. Lab Invest, 2011, 91 (10) : 1459 -1471.
  • 4Utimura R, Fujihara CK, MattarAL, et al. Mycophenolate mofetil p revents the development of glomerular injury in experimental diabetes [J]. Kidney Int, 2003, 63(1) : 209 -216.
  • 5Banba N, Nakamura T, Matsumura M, et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy [ J ]. Kidney Int, 2000, 58(2) : 684 -690.
  • 6Riser BL, Meeran K, Rambow J, et al. Urinary monocyte chemoat- tractant protein-1 (MCP-1) and connective tissue growth factor ( CCN2 ) as prognostic markers for progression of diabetic nephropathy [J]. Cytokine, 2009, 47(1) : 37 -42.
  • 7Mezzano S, Aros C, Droguett A, et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy [ J ]. Nephrol Dial Transplant, 2004 , 19 (10) : 2505 - 2512.
  • 8Soetikno V, Sari FR, Veeraveedu PT, et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-KB activation and proinflam- matory cytokines in streptozotocin induced-diabetic nephropathy [ J ]. Nutr Metab (Lond), 2011 , 8(1): 35.
  • 9Ide Y, Matsui T, Ishibashi Y, et al. Pigment epithelium-derived fac- tor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappa B activation [ J ]. Microvasc Res, 2010, 80(2): 227-232.
  • 10Wu Y, Dong J, Yuan L, et al. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy [J]. Cytokine, 2008, 44(1): 85 -91.

共引文献5

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部